Finance Knuggets

Jan 29, 2024 I recently heard that U.S. Steel’s acquisition by Japan’s Nippon Steel was driven by regulatory arbitrage rather than price, as revealed in its preliminary proxy statement. Additionally, CG Oncology, a biotech company focused on bladder cancer, raised $380 million in its IPO, signaling a positive trend in

Continue readingFinance Knuggets

Finance Knuggets

Jan 26, 2024 I recently heard that U.S. Steel’s acquisition by Japan’s Nippon Steel was driven by regulatory arbitrage rather than price, as revealed in its preliminary proxy statement. CG Oncology, a biotech company focused on bladder cancer, raised $380 million in its IPO, signaling a positive trend in the

Continue readingFinance Knuggets